Advanced Solid Tumors
Advanced solid tumors are a type of cancer that forms a mass in solid organs or tissues, such as the lungs, breast, or colon, and have progressed to a more severe stage, often requiring more intensive treatment.
Solid Tumors: NECVAX-NEO1 with PD-1/PD-L1 Therapy
We are studying a new treatment, NECVAX-NEO1, for patients with solid tumors already on PD-1 or PD-L1 therapy. The trial aims to assess its safety and how well it may work in combination with existing treatments.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Are you currently pregnant or breastfeeding?
- Do you have any serious health issues like uncontrolled high blood pressure, severe heart problems, or active infections?
- Are you taking any blood thinners like Warfarin, Eliquis, or Xarelto?
- Have you had any major surgeries in the last 3 months?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Necvax Neo1
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Charite Universitaetsmedizin Berlin KöR
Hematology and Oncology
Berlin, Germany
Universitaetsklinikum Heidelberg AöR
Medizinische Onkologie
Heidelberg, Germany
Klinikum rechts der Isar der TU Muenchen AöR
Gastroenterology and Intern medicine
Munich, Germany
Sponsor: NEC Bio Therapeutics GmbH
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.